Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,753 | 96,339 | 24,487 | 42,748 | 157,150 |
| Marketable Securities | N/A | N/A | 54,590 | 46,221 | N/A |
| Other current assets | 2,276 | 1,968 | 1,211 | 396 | 276 |
| TOTAL | $44,206 | $102,183 | $83,608 | $91,895 | $160,397 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 32,459 | 0 |
| Other Non-Current Assets | 1,003 | 1,763 | 2,040 | 2,132 | 2,486 |
| TOTAL | $1,003 | $1,763 | $2,040 | $34,591 | $2,486 |
| Total Assets | $45,209 | $103,946 | $85,648 | $126,486 | $162,883 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,622 | 1,622 | 1,622 | N/A | 2,554 |
| Accounts payable and accrued liabilities | 1,295 | 3,332 | 1,426 | 2,823 | 3,628 |
| Accrued Expenses | 12,329 | 14,600 | 9,399 | 6,048 | 3,581 |
| TOTAL | $15,246 | $24,465 | $12,447 | $8,871 | $9,763 |
| Non-Current Liabilities | |||||
| Long Term Debt | 124 | 1,717 | 3,293 | 4,878 | 1,922 |
| Deferred Revenues | N/A | 4,911 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,018 | 1,255 | 1,422 | 1,366 | 1,771 |
| TOTAL | $1,142 | $2,972 | $4,715 | $6,244 | $3,693 |
| Total Liabilities | $16,388 | $27,437 | $17,162 | $15,115 | $13,456 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 562 | 547 | 529 | 312 | 310 |
| Common Shares | 4 | 4 | 3 | 3 | 2 |
| Retained earnings | -250,268 | -197,232 | -149,313 | -103,133 | -60,841 |
| Other shareholders' equity | 0 | 0 | -558 | -184 | 0 |
| TOTAL | $28,821 | $76,509 | $68,486 | $111,371 | $149,427 |
| Total Liabilities And Equity | $45,209 | $103,946 | $85,648 | $126,486 | $162,883 |